Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Emphysema Treatment Market Evolve in Terms of Growth and Size by 2029?

In recent years, we have observed a consistent growth in the emphysema treatment market. The market size is projected to increase from $5.15 billion in 2024 to $5.4 billion in 2025, implying a compound annual growth rate (CAGR) of 5.0%. The expansion observed during the historic period was a result of the effect of the smoking epidemic, advancements in medicine, implementation of pulmonary rehabilitation programs, the development of better diagnostic tools, and increased awareness and education.

The market size for emphysema treatment is projected to experience robust expansion in the coming years, reaching $7.28 billion in 2029 with a CAGR of 7.7%. The expected growth during the forecast period can be attributed to factors such as the ageing population, personalized treatment methods, broader access to treatment, concentration on symptom management, and the implementation of cooperative healthcare models. Emerging trends during this forecast period encompass the investigation into gene therapies, the push for patient enlightenment and autonomy, the integration of AI, the enhancement of treatment accessibility, and the development of long-lasting medications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What factors are expected to fuel Emphysema Treatment market growth in the coming years?

The increase in the number of chronic obstructive pulmonary disease (COPD) cases is predicted to spur the growth of the emphysema treatment market. COPD, a group of conditions that cause airflow obstruction and breathing difficulties, includes emphysema and chronic bronchitis. Emphysema treatments target relieving symptoms, restoring lung function, and slowing down the disease’s progression, hence crucial in mitigating the impact of COPD. For example, as the Australian Institute of Health and Welfare (AIHW) reported in June 2024, it was estimated in 2022 that about 638,000 people or 2.5% of Australia’s population lived with COPD. By 2023, the occurrence of COPD had increased to represent 3.6% of the entire disease burden, contributing to half of the total burden relating to respiratory conditions. In 2022, COPD was the fundamental cause of 7,691 deaths, which represents 29.6 deaths per 100,000 people and accounts for 4.0% of all deaths in the nation. As such, the escalating prevalence of COPD is a driving factor in the expansion of the emphysema treatment market.

What Are The Key Findings From The Segmentation Analysis Of The Emphysema Treatment Market?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Which Trends Are Expected To Shape The Future Of The Emphysema Treatment Market?

Foremost corporations in the emphysema market are spearheading the development of minimally invasive procedures for patients suffering from emphysema to establish their dominance in the industry. More specifically, minimally invasive procedures allude to medical treatments or surgical methods that cause the least disturbance to the body’s usual functions. For instance, Adena Health System, a health service company based in the US, introduced the Zephyr Valve surgery in January 2022. This less invasive operation offers an alternative to traditional lung volume reduction surgery for patients dealing with lung hyperinflation, a widespread issue in both emphysema and COPD. This novel method includes implanting small, one-directional Zephyr Valves into the lung’s airways through a bronchoscope. These valves enable the expulsion of trapped air, halting any further accumulation, and permit healthier parts of the lung to enlarge, leading to improved respiration.

What Are The Most Active Companies In The Emphysema Treatment Market Today?

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Which Regional Markets Are Attracting The Most Investment In Emphysema Treatment?

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model